Predictor markers of early pulmonary hypertension in patients with collagen diseases

I. Tiglea, M. Popescu, A. Dumitrascu, D. Marta, E. Iordachita, E. Moldoveanu, C. Tanaseanu (Bucharest, Romania)

Source: Annual Congress 2010 - Pulmonary hypertension
Session: Pulmonary hypertension
Session type: E-Communication Session
Number: 3521
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Tiglea, M. Popescu, A. Dumitrascu, D. Marta, E. Iordachita, E. Moldoveanu, C. Tanaseanu (Bucharest, Romania). Predictor markers of early pulmonary hypertension in patients with collagen diseases. Eur Respir J 2010; 36: Suppl. 54, 3521

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J 2014; 44: 951-962
Year: 2014



Predictor factors of mortality in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018


Prognostic risk factors of disease worsening in patients with functional class II pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Risk assessment in severe pulmonary hypertension due to interstitial lung disease
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Determination of pulmonary hypertension degree in patients with interstitial lung diseases
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Biomarkers for pulmonary hypertension in interstitial lung disease
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011


Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019

Correlation between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Year: 2007


Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Biological markers predictors of pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Year: 2021



Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Relationship between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Women: lung and autoimmune disease
Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=190
Year: 2003